These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10588333)
1. Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo. Kloover JS; Scholz M; Cinatl J; Lautenschlager I; Grauls GE; Bruggeman CA Antiviral Res; 1999 Nov; 44(1):55-65. PubMed ID: 10588333 [TBL] [Abstract][Full Text] [Related]
2. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection. Martelius T; Scholz M; Krogerus L; Höckerstedt K; Loginov R; Bruggeman C; Cinatl J; Doerr HW; Lautenschlager I Transplantation; 1999 Dec; 68(11):1753-61. PubMed ID: 10609953 [TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid. Cinatl J; Hoffmann F; Cinatl J; Weber B; Scholz M; Rabenau H; Stieneker F; Kabickova H; Blasko M; Doerr HW Antiviral Res; 1996 Jun; 31(1-2):23-34. PubMed ID: 8793006 [TBL] [Abstract][Full Text] [Related]
4. An animal model of neonatal cytomegalovirus infection. Bravo FJ; Bourne N; Schleiss MR; Bernstein DI Antiviral Res; 2003 Sep; 60(1):41-9. PubMed ID: 14516920 [TBL] [Abstract][Full Text] [Related]
5. Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection. Tan L; Sato N; Shiraki A; Yanagita M; Yoshida Y; Takemura Y; Shiraki K Antiviral Res; 2019 Feb; 162():30-38. PubMed ID: 30543830 [TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Cinatl J; Cinatl J; Rabenau H; Gümbel HO; Kornhuber B; Doerr HW Antiviral Res; 1994 Sep; 25(1):73-7. PubMed ID: 7811060 [TBL] [Abstract][Full Text] [Related]
7. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic cell stimulation enhances cytomegalovirus replication in the early period of primary infection in an experimental rat model. Tamura K; Oka T; Ohsawa K; Koji T; Watanabe Y; Katamine S; Sato H; Ayabe H J Heart Lung Transplant; 2003 Apr; 22(4):452-9. PubMed ID: 12681423 [TBL] [Abstract][Full Text] [Related]
9. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Neyts J; De Clercq E Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749 [TBL] [Abstract][Full Text] [Related]
10. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs. Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690 [TBL] [Abstract][Full Text] [Related]
11. Effects of acute cytomegalovirus infection on rat islet allograft survival. Smelt MJ; de Haan BJ; Faas MM; Melgert BN; de Haan A; de Vos P Cell Transplant; 2011; 20(8):1271-83. PubMed ID: 21176406 [TBL] [Abstract][Full Text] [Related]
12. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. Balthesen M; Dreher L; Lucin P; Reddehase MJ J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives. Baba M; Konno K; Shigeta S; Wickramasinghe A; Mohan P Antiviral Res; 1993 Mar; 20(3):223-33. PubMed ID: 8385895 [TBL] [Abstract][Full Text] [Related]
14. Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection. Deng J; Xiao J; Ma P; Gao B; Gong F; Lv L; Zhang Y; Xu J Viruses; 2017 May; 9(5):. PubMed ID: 28534856 [TBL] [Abstract][Full Text] [Related]
15. Analysis of cytomegalovirus infection and replication in acinar epithelial cells of the rat lacrimal gland. Huang Z; Lambert RW; Wickham LA; Sullivan DA Invest Ophthalmol Vis Sci; 1996 May; 37(6):1174-86. PubMed ID: 8631632 [TBL] [Abstract][Full Text] [Related]
16. Rat cytomegalovirus replication in the salivary glands is exclusively confined to striated duct cells. Kloover JS; Hillebrands JL; de Wit G; Grauls G; Rozing J; Bruggeman CA; Nieuwenhuis P Virchows Arch; 2000 Oct; 437(4):413-21. PubMed ID: 11097367 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Bruning JH; Persoons M; Lemström K; Stals FS; De Clercq E; Bruggeman CA Transpl Int; 1994; 7 Suppl 1():S365-70. PubMed ID: 11271253 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiviral activity of different origin compounds by flow cytometry. Siennicka J; Trzcińska A; Kańtoch M Acta Microbiol Pol; 2002; 51(1):79-83. PubMed ID: 12184452 [TBL] [Abstract][Full Text] [Related]
19. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Stals FS; Bosman F; van Boven CP; Bruggeman CA Arch Virol; 1990; 114(1-2):91-107. PubMed ID: 2171466 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Beljaars L; van der Strate BW; Bakker HI; Reker-Smit C; van Loenen-Weemaes AM; Wiegmans FC; Harmsen MC; Molema G; Meijer DK Antiviral Res; 2004 Sep; 63(3):197-208. PubMed ID: 15451188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]